Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€15.20
06.04.24
-
06.04.25
-17.11%
02.05.24

buy
Lifeway Foods Inc.

Start price
Target price
Perf. (%)
€18.70
06.04.24
-
06.04.25
3.21%
02.05.24

Trevena Inc.

Start price
Target price
Perf. (%)
€0.35
06.04.24
-
06.04.25
-7.33%
02.05.24

buy
Staar Surgical Co.

Start price
Target price
Perf. (%)
€45.07
06.04.24
-
06.04.25
-5.86%
02.05.24

buy
Kontron AG

Start price
Target price
Perf. (%)
€19.12
06.04.24
-
06.04.25
1.15%
03.05.24

buy
Kontron AG

Start price
Target price
Perf. (%)
€19.12
06.04.24
-
06.04.25
1.15%
03.05.24

buy
Axt Inc.

Start price
Target price
Perf. (%)
€2.87
05.04.24
€5.07
05.04.25
18.16%
03.05.24

buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€1,494.0
05.04.24
€1,661.8
05.04.25
-24.00%
03.05.24

buy
R1 RCM Inc.

Start price
Target price
Perf. (%)
€11.70
05.04.24
€13.85
05.04.25
-0.85%
02.05.24

Plug Power Inc.

Start price
Target price
Perf. (%)
€2.79
05.04.24
€1.85
05.04.25
-8.89%
03.05.24

buy
Aerovironment

Start price
Target price
Perf. (%)
€134.60
05.04.24
€152.59
05.04.25
16.42%
03.05.24

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€64.00
05.04.24
€75.83
05.04.25
0.00%
03.05.24

buy
Lifeway Foods Inc.

Start price
Target price
Perf. (%)
€17.90
05.04.24
€23.12
05.04.25
25.14%
02.05.24

First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€6.89
05.04.24
-
05.04.27
-9.70%
03.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€4.20
04.04.24
-
04.04.27
1.62%
03.05.24

Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
buy
Clean Energy Fuels Corp.

Start price
Target price
Perf. (%)
€2.29
03.04.24
€4.61
03.04.25
-3.84%
03.05.24

buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.58
03.04.24
€12.01
03.04.25
4.37%
03.05.24

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€62.50
03.04.24
€79.68
03.04.25
2.40%
03.05.24

buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€28.10
03.04.24
-
03.04.25
2.31%
03.05.24

buy
Accelerate Diagnostics Inc.

Start price
Target price
Perf. (%)
€0.87
02.04.24
-
02.04.25
0.00%
02.05.24

buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.37
02.04.24
€19.50
02.04.25
-13.24%
02.05.24

buy
Trevena Inc.

Start price
Target price
Perf. (%)
€0.33
02.04.24
€8.37
02.04.25
12.08%
02.05.24

Hypoport SE

Start price
Target price
Perf. (%)
€234.60
02.04.24
-
02.04.25
9.72%
03.05.24

Mag Silver Corp.

Start price
Target price
Perf. (%)
€9.99
02.04.24
-
02.04.25
13.91%
03.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
buy
Barrett Business Services Inc.

Start price
Target price
Perf. (%)
€117.00
01.04.24
€131.24
01.04.25
-3.42%
02.05.24